NCT04083378View on ClinicalTrials.gov

Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

January 10, 2020

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2026

Conditions
Malignant Liver Neoplasm
Interventions
PROCEDURE

Ablation Therapy

Undergo standard of care ablation

PROCEDURE

Image-Guided Therapy

Undergo software-aided imaging (Morfeus)

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER